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Soluble oligomers are sufficient for transmission of a
yeast prion but do not confer phenotype
Jennifer E. Dulle, Rachel E. Bouttenot, Lisa A. Underwood, and Heather L. True
Department of Cell Biology and Physiology, Washington University in St. Louis, St. Louis, MO 63110

that they are soluble and less resistant to SDS. We found
that large, SDS-resistant aggregates were required for the
prion phenotype but that soluble, more SDS-sensitive oligomers contained all the information necessary to transmit the
prion conformation. Thus, we identified distinct functional
requirements of two types of prion species for this endogenous epigenetic element. Furthermore, the nontoxic, selfreplicating amyloid conformers of yeast prion proteins have
again provided valuable insight into the mechanisms of
amyloid formation and propagation in cells.

Introduction
The amyloid hypothesis proposes that large, protease-resistant
amyloid fibers underlie the toxicity associated with several
neurodegenerative diseases (Caughey and Lansbury, 2003;
Chiti and Dobson, 2006). A definitive link between the amyloid
aggregate and toxicity and neurodegeneration has not been
established (Haass and Selkoe, 2007). A recent alternative
proposal posits that an intermediate in the amyloid pathway is
the primary toxic agent, while the large, insoluble aggregates
may sequester oligomers and perhaps aid in cell survival
(Kirkitadze et al., 2002). Soluble oligomers of several amyloidogenic proteins including amyloid-, huntingtin, -synuclein,
and PrP have been detected both from analysis of amyloidforming recombinant proteins and in cell and mouse models
(Lasmézas et al., 1997; Conway et al., 1998; Tzaban et al.,
2002; Sánchez et al., 2003; Silveira et al., 2005; Lesné et al.,
2006; Sajnani et al., 2012). These oligomers, characterized
as putative intermediates in amyloid formation, encompass a
variety of sizes and structures that cause toxicity when introduced into disease models (Klyubin et al., 2005; Silveira
et al., 2005; Sajnani et al., 2012). Isolation of these dynamic, soluble oligomers has remained largely elusive and,

as such, investigation of their role in amyloid formation has
proven challenging.
The yeast prion protein Sup35 forms self-perpetuating
amyloid conformers that are transmissible and infectious
(Patino et al., 1996; Paushkin et al., 1996; Serio et al., 2000).
To propagate the [PSI+] prion, Sup35 aggregates must undergo remodeling by the chaperone Hsp104, which facilitates
monomer addition by severing amyloid structures to generate
transmissible species, or propagons (Chernoff et al., 1995;
Kryndushkin et al., 2003; Shorter and Lindquist, 2006; SatputeKrishnan et al., 2007). Until now, in vivo studies have primarily reported on the role of Hsp104 in aggregate fragmentation
(Ness et al., 2002; Satpute-Krishnan et al., 2007). Interestingly,
Hsp104 has also been shown to catalyze amyloid formation
in vitro, specifically impacting the formation of amyloid oligomers (Shorter and Lindquist, 2004). Moreover, recent in vitro
evidence identified Sup35 oligomers as intermediates during
amyloid formation under some conditions (Ohhashi et al.,
2010). Here, we identify soluble, more SDS-sensitive oligomers of Sup35 as prion propagons and show that Hsp104 plays
a role in their maintenance.
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myloidogenic proteins aggregate through a selftemplating mechanism that likely involves oligomeric or prefibrillar intermediates. For diseaseassociated amyloidogenic proteins, such intermediates have
been suggested to be the primary cause of cellular toxicity.
However, isolation and characterization of these oligomeric
intermediates has proven difficult, sparking controversy over
their biological relevance in disease pathology. Here, we
describe an oligomeric species of a yeast prion protein in
cells that is sufficient for prion transmission and infectivity.
These oligomers differ from the classic prion aggregates in
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We performed a screen to identify cellular changes that rescued cells from toxic overexpression of SUP35 in [PSI+] cells
(Vishveshwara et al., 2009). As this toxicity is dependent on
[PSI+], we expected to uncover factors that affected Sup35
aggregation. One mutation identified, hsp104-R830S in the
C-terminal domain of Hsp104, caused [PSI+] cells to appear
phenotypically [psi] by a readout of translation termination
efficiency of a reporter that is indicative of the functional,
soluble state of Sup35 (Fig. 1 A). Fluorescent imaging showed
that Sup35 in hsp104-R830S cells appeared diffuse (Fig. 1 B), and
by semi-denaturing detergent-agarose gel electrophoresis (SDDAGE), only monomeric Sup35 was detected in hsp104-R830S
cells (Fig. 1 C). Strikingly, mating hsp104-R830S cells that appeared [psi] to wild-type HSP104 [psi] cells produced many
diploids that were phenotypically [PSI+], as seen by increased
nonsense suppression (Fig. S1). Furthermore, sporulation of these
diploids produced two [PSI+] and two [psi] haploid progeny
(Fig. 1 D), thereby indicating that prion-competent propagons
had been maintained in hsp104-R830S cells that resulted in cryptic [PSI+] (phenotypically undetectable). Indeed, transformation
of hsp104-R830S cell lysates into wild-type [psi] cells demonstrated that these propagons were infectious and produced [PSI+]
cells. Out of 1,154 cells transformed, 45 were [PSI+] (3.9% infectivity). Control transformations of [psi] lysates into [psi]
cells resulted in only red colonies. Of the thousands of red colonies resulting from these control transformations, over 400 were
further analyzed and confirmed to be [psi]. Thus, the infectious
propagon in hsp104-R830S cells is unable to cause observable
nonsense suppression, but reestablishes and maintains the [PSI+]
phenotype in the presence of wild-type HSP104.
Hsp104 normally functions to disaggregate nonprion aggregates and promote cellular recovery from stress (Glover and
Lindquist, 1998). Therefore, we tested the activity of the Hsp104R830S mutant with other known substrates. Interestingly, the
thermotolerance of hsp104-R830S cells resembled that of wildtype cells (Fig. 2 A). Moreover, hsp104-R830S cells efficiently
resolubilized heat-aggregated luciferase (Fig. 2 B). Hsp104
threads substrates through a central channel as a mechanism of
disaggregation (Tessarz et al., 2008). The Hsp104 variant, HAP,
has been used to investigate threading activity by coupling
Hsp104 to the ClpP protease so that threaded substrates are
degraded, resulting in decreased viability (Tessarz et al., 2008).
We created the HAP-R830S variant and found that the mutant
maintained threading activity (Fig. 2 C). Hsp104 is an AAA+
ATPase. Mutations that inhibit ATP hydrolysis or hexamerization typically prevent [PSI+] propagation (Glover and Lum,
2009). We purified Hsp104-R830S and measured a reduced initial rate of ATP hydrolysis of 0.1659 ± 0.0308 nmol Pi·µg1·min1,
as compared with the initial rate of wild-type Hsp104 of 0.2975 ±
0.412 nmol Pi·µg1·min1, which is comparable to previously
published data (Tkach and Glover, 2004). We next analyzed the
distribution of Hsp104-R830S, relative to wild-type Hsp104,
using glycerol gradients and size-exclusion chromatography.
These analyses revealed that Hsp104-R830S forms unstable
hexamers (Fig. 2 D and Fig. S2). Together, these data reveal

that the reduced activity of Hsp104-R830S impairs the maintenance of the [PSI+] phenotype.
Next, we assessed the state of Sup35 in hsp104-R830S
cryptic [PSI+] cells. We first performed sedimentation analysis
with hsp104-R830S cryptic [PSI+] lysates and found that Sup35
was soluble (Fig. 3 A). Next, we subjected lysates of hsp104R830S cryptic [PSI+] and HSP104 [psi] cells to sucrose gradient fractionation. Monomeric Sup35 in [psi] cells remained in
the top fractions, while Sup35 from hsp104-R830S lysates was
detected further down the gradient, demonstrating the existence
of some oligomeric species (Fig. 3 B). To understand how these
oligomers relate to the large SDS-resistant aggregates associated
with the [PSI+] phenotype, we created a system to examine the
effect of hsp104-R830S on pre-existing Sup35 aggregates. We
covered hsp104-R830S cryptic [PSI+] with wild-type HSP104
expressed from a glucose-repressible promoter such that cells
grown in nonrepressing galactose allowed the propagation of
[PSI+] and maintained SDS-resistant aggregates (Fig. 3 C, Gal).
We then shifted the cells to glucose to repress wild-type HSP104
(Fig. S3 A) and performed SDD-AGE to monitor the effect of
hsp104-R830S on SDS-resistant Sup35 aggregates. Within 12 h
of wild-type HSP104 repression, monomeric Sup35 was apparent in hsp104-R830S cells. Within 24 h, SDS-resistant aggregates
had disappeared (Fig. 3 C). As expected, when hsp104-R830S
pGAL-HSP104 cells were switched from glucose back to
galactose to de-repress wild-type HSP104, they became phenotypically [PSI+] (Fig. S3 B). Therefore, despite the loss of
SDS-resistant aggregates, the propagons remained. Thus, the
large SDS-resistant Sup35 aggregates are not strictly required for
transmission of the prion.
We therefore reasoned that a less stable subpopulation of
Sup35 might be capable of prion transmission. Indeed, that the
addition of SDS to Sup35 prion aggregates results in smaller
SDS-resistant polymers suggests that some less SDS-resistant
species exists within the large prion aggregates (Kryndushkin
et al., 2003). We investigated whether the soluble oligomers in
hsp104-R830S cryptic [PSI+] cells were less resistant to SDS,
as has been reported for another prion (Taneja et al., 2007). We
again performed SDD-AGE on hsp104-R830S cryptic [PSI+]
lysates but decreased the SDS concentration, and only then did
we observe the presence of oligomeric species (Fig. 3 D). To
determine how these species related to prion propagons and the
cryptic [PSI+] phenotype, we repeated the wild-type HSP104
repression time course with hsp104-R830S cells using a low-SDS
SDD-AGE. We observed the maintenance of less SDS-resistant,
oligomeric species throughout the time course (Fig. 3 E), suggesting that the soluble, less SDS-resistant oligomers are the transmissible propagons in hsp104-R830S cryptic [PSI+] cells.
Although we observed the unstable, soluble oligomers in
the absence of insoluble aggregates, it is likely that both species
exist in wild-type cells, and the more SDS-sensitive, soluble
oligomers are more readily detectable in cells lacking insoluble
aggregates. Therefore, we separated the Sup35 species in both
hsp104-R830S cryptic [PSI+] and wild-type [PSI+] cells by sucrose gradient and performed protein transformation to determine
whether the soluble fractions contained infectious propagons.
Both hsp104-R830S and HSP104 cells contained soluble Sup35
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Figure 1. hsp104-R830S propagates cryptic [PSI+]. (A) [PSI+], [psi], and hsp104-R830S cells were spotted on media containing CuSO4 to induce toxic
overexpression of Sup35, media lacking adenine (SD-Ade) to assess nonsense suppression of the premature stop codon in ade1-14, and rich media (YPD).
(B) HSP104 [PSI+] and hsp104-R830S cells containing pSup35NM-GFP were imaged by fluorescence microscopy. Bar, 10 µm. (C) Western blot of an
SDS-containing agarose gel (SDD-AGE) shows Sup35 aggregate status in lysates of indicated strains. This blot is one representative of three individual
experiments. (D) An example of two tetrads where mating hsp104-R830S to [psi] cells, both containing the ade1-14 mutation, resulted in tetrads with two
red (efficient translation termination, hsp104-R830S) and two light pink (increased nonsense suppression, [PSI+] HSP104) haploids.
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oligomers that were infectious to [psi] cells (Fig. 4 A).
Although much of the Sup35 species from wild-type lysates migrated to the bottom of the gradient (35% of the total Sup35
which correspond to 54% of the infectivity), there were highly
infectious oligomers in wild-type [PSI+] cells that did not migrate with the heavy-sedimenting aggregates. This soluble pool
of Sup35 contains 46% of the infectivity in wild-type [PSI+]
lysates. Curiously, the high-molecular weight aggregates observed in hsp104-R830S cells were not very infectious, suggesting that these aggregates are not the same high-molecular
weight aggregates present in wild-type [PSI+] cells and are not
efficient [PSI+] propagons. We then performed a simple solubility assay to separate wild-type [PSI+] lysates into soluble
and insoluble fractions (see Fig. 3 A), and then performed infectivity assays and SDD-AGE analysis. Strikingly, we found
much of the infectivity in the soluble fraction (32.8% of the
total Sup35, which corresponds to 30% of the infectivity) from
sedimentation analysis (Fig. 4 B). Additionally, by SDD-AGE,
we found that there were no Sup35 oligomers resistant to 2%
SDS in the soluble fraction (Fig. 4 C). As such, these data support our hypothesis that insoluble aggregates are not strictly required for prion transmission.
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Propagons contain the variant-specific properties required
for inheritance and propagation of distinct prion phenotypes
(Tanaka et al., 2004; Satpute-Krishnan and Serio, 2005). Therefore, the soluble oligomers in hsp104-R830S cryptic [PSI+] cells
should retain the properties necessary to propagate the parental
strong [PSI+] phenotype. If hsp104-R830S altered the prion structure, instead of cryptic [PSI+], weakened nonsense suppression and enhanced mitotic loss could be expected. After crossing
hsp104-R830S cryptic [PSI+] cells to [psi] cells, we compared
the [PSI+] meiotic progeny to the parental strong [PSI+] variant
used initially in the screen. We found that the [PSI+] progeny were
indeed strong [PSI+] phenotypically (Fig. 4 D). We then performed SDD-AGE analysis of the resulting [PSI+] haploids as
compared with the strong [PSI+] and a weak [PSI+] variant
(Derkatch et al., 1996; Kryndushkin et al., 2003; Bagriantsev
and Liebman, 2004). The SDS-resistant Sup35 aggregates in
the [PSI+] progeny appear the same as strong [PSI+] (Fig. 4 E).
We also noted that all the [PSI+] transformants from infection
of hsp104-R830S lysates into [psi] cells were strong [PSI+].
Thus, Hsp104-R830S did not alter the properties of the original
variant phenotypically or biochemically, suggesting that there
was no change in prion structure.
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Figure 2. Analysis of Hsp104-R830S activity reveals the mechanism of altered activity. (A) Growth on YPD plates of the strains heat-shocked at 50°C for
times indicated. Untreated cells were spotted before heat shock. (B) HSP104 (black), hsp104-R830S (red), and hsp104 (orange) cells expressing heataggregatable luciferase were heat-shocked at 44°C while blocking new protein synthesis. Luminescence during recovery at 30°C was plotted as a fraction
of luminescence before heat shock. Error bars represent the SD. (C) hsp104 cells carrying pRS315CUP1-ClpP, covered by the indicated plasmids, were
spotted on media containing CuSO4 to induce expression of ClpP. (D) Hsp104 (top) and Hsp104-R830S (bottom) incubated with and without ATP (red/
black) separated on a glycerol gradient by ultracentrifugation. This is one representation of three individual experiments. The top of the gradient is fraction
number 1. Fractions were analyzed by SDS-PAGE and Western blot. All experiments were repeated at least three times.
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We have shown, for the first time, the presence of soluble,
prion-competent, less SDS-resistant oligomers of Sup35 in vivo.
The less SDS-resistant, soluble oligomers are sufficient for transmission of the prion conformation, but are not sufficient to produce the nonsense suppression phenotype associated with [PSI+].
We have also shown that the insoluble aggregates that characterize

Downloaded from jcb.rupress.org on December 10, 2013

Figure 3. hsp104-R830S propagates SDSsensitive soluble oligomers of Sup35. (A) Ultracentrifugation separated lysates into total (T),
soluble (S), and pellet (P) fractions. (B) Fractionation of [psi] and hsp104-R830S cryptic
[PSI+] lysates separated by a 3-h centrifugation
through a linear sucrose gradient. (C) Hsp104
and hsp104-R830S cells carrying p416GALHSP104 grown in galactose were switched
to glucose to repress p416GAL-HSP104, and
p416GAL-HSP104 was efficiently repressed
by 12 h in glucose as shown by Western blot
in an hsp104 control (Fig. S3). Aliquots were
taken from galactose and between 12 and 72 h
in glucose and subjected to SDD-AGE. The
shift in aggregate distribution occurs when
changing carbon sources. (D) Lysates of the
indicated strains were analyzed by SDD-AGE.
The HSP104 [PSI+] and [psi] and hsp104R830S samples were incubated in sample
buffer containing the indicated percentages of
SDS. (E) Same as D, but samples were subjected to SDD-AGE containing 0.01% SDS.
All experiments were repeated at least three
times and protein molecular weight markers
(kD) are indicated.

[PSI+] cells are not required for prion transmission or infectivity.
Furthermore, we have uncovered two novel features of yeast
prion propagons. First, they can be more SDS sensitive, where
previously only SDS-resistant aggregates of Sup35 were shown
to be infectious (Bagriantsev et al., 2008). This sensitivity parallels the previously described PK-sensitive PrP species, which
Soluble oligomers maintain prions, not phenotype • Dulle et al.
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Materials and methods
Strains and yeast cultivation
The yeast strains used in this study are derivatives of Saccharomyces cerevisiae 74-D694 and were grown using standard culture techniques. YPD is
rich yeast medium, whereas SD is synthetic medium lacking amino acids as
needed to select for maintenance of plasmids or screen for a nonsense suppression phenotype (SD-Ade). The strain used in the screen, 74-D694 [PSI+]
can1::MFA1pr-HIS3-MFa1p r-LEU2 ade1-14 ura3-52 lys2::KanMX4
pRS315CUP1-SUP35, was transformed with 10 independent plasmid pools

Figure 4. Soluble oligomeric [PSI+] propagons are infectious and maintain the prion variant structure. (A) Fractions of [PSI+] and hsp104-R830S
cryptic [PSI+] lysates separated on a linear sucrose gradient by a 22-h
ultracentrifugation step were analyzed by Western blot and the amount of
Sup35 (presented as the percent of soluble Sup35) in each fraction was
quantified by ImageJ (National Institutes of Health) and is indicated below
each fraction in the Western blot. Equal volumes of each fraction were
transformed into [psi] cells. The fraction of infected [PSI+] cells obtained
from each gradient fraction is indicated for hsp104-R830S (black) and
HSP104 (gray) cells. The fraction of infected [PSI+] cells was generated by
compiling the infectivity data from four (HSP104) or five (hsp104-R830S)
separate sucrose gradients and transformations. Sup35 in hsp104-R830S
lysates appears to be more susceptible to proteolysis and frequently shows
degradation products. Protein molecular weight markers (kD) are indicated.
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(B) Total, soluble, and insoluble fractions of HSP104 [PSI+] lysates from
sedimentation analysis were transformed into [psi] cells. The relative infectivity of the total, soluble, and insoluble fractions was calculated as
above and is indicated. (Inset) A Western blot for Sup35 in total (T), soluble (S), and insoluble (I) fractions from one sedimentation assay in this
experiment with protein molecular weight marker (kD). Of the thousands of
red colonies resulting from transformation of the soluble and insoluble fractions from wild-type [psi] cells as a negative control, further analysis verified that 48 from each fraction were [psi] in each of three independent
experiments. (C) Total (T), soluble (S), and insoluble (I) fractions of HSP104
[PSI+] lysates from sedimentation analysis were analyzed by SDD-AGE.
The soluble fraction is from the top of the supernatant to prevent contamination from the pellet. This experiment was repeated three times. (D) Two
representative tetrads from the mating of hsp104-R830S cryptic [PSI+] to
[psi] were spotted on YPD (top) and SD-Ade plates (bottom) to assess the
level of nonsense suppression. Strong [PSI+] (Control A), weak [PSI+] (Control B), and [psi] (Control C) strains were spotted for reference. (E) The
lysates of the four white haploids from the tetrads in C were analyzed by
SDD-AGE and compared with strong (St) and weak (Wk) [PSI+] controls.
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can also transmit the prion (Sajnani et al., 2012). Second, soluble
oligomers were able to act as propagons in vivo. Oligomers of several amyloidogenic proteins have been described and can cause
toxicity in the absence of large aggregates (Haass and Selkoe,
2007). Indeed, our data correlate well with previous reports that
visible Sup35 aggregates are lost in the mother cell and yet the
prion is faithfully propagated (Taguchi and Kawai-Noma, 2010).
Perhaps the SDS-resistant, insoluble Sup35 aggregates function
as a reservoir for the continued renewal of transmissible propagons. This role for SDS-resistant yeast prion aggregates mirrors
the proposed role for amyloid aggregates as traps for oligomers
(Kirkitadze et al., 2002). As such, we clearly show separate functions of two distinct aggregate species that are structurally related
components of the same prion propagation pathway. A mutant in
Hsp104 enabled us to initially tease out these species. We favor
a model whereby the decreased activity of hsp104-R830S results
in reduced fragmentation of aggregates, but our data do not exclude the possibility that Hsp104 normally plays a role in generating the large insoluble aggregates.
The soluble oligomers that exist in many protein conformational disorders are challenging to characterize due to their
dynamic and metastable nature. In addition, conflicting reports
on the properties and structure of oligomers complicate the elucidation of the important oligomeric species (Haass and Selkoe,
2007). The properties and mechanisms associated with yeast
prion propagons may be similar to those associated with amyloidogenic proteins involved in self-propagating protein conformational disorders. Therefore, investigating these features may
lead to a better understanding of the function and structure of
soluble, self-templating oligomers, as well as the role of amyloid in disease.
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of the mini-transposon (3XHA/lacZ(mTn3)) mutagenized library (provided
by M. Snyder, Stanford University, Stanford, CA) and selected on media
containing 350 µM copper sulfate to induce expression of SUP35. Candidates that rescued toxicity associated with increased expression of SUP35
were passaged a second time on copper sulfate media and were examined
for the effect on [PSI+] phenotypically by color and genetically by mating to
unmutagenized 74-D694 [PSI+] and [psi] isogenic strains. Several mutants, not linked to the transposon, were analyzed and determined to be in
Hsp104 through genetic analysis. The mutant characterized here, hsp104R830S, was recreated and these strains were used for further characterization. Phenotypic assays are based on the amount of functional Sup35 to
terminate the premature stop codon in ade1-14, which results in the accumulation of a red-pigmented intermediate in the adenine biosynthesis pathway
(Liebman and Derkatch, 1999).

Fluorescence microscopy
Cells were transformed with pRS426CUP1-SUP35NM-GFP and grown in
media lacking uracil. 50 µM CuSO4 was added to logarithmically growing
cells and grown for 4 h to induce expression of SUP35NM-GFP. Images of
cells expressing Sup35NM-GFP, in water and at room temperature, were
captured on a microscope (Bmax-60F; Olympus) containing a 1.35 NA/100×
UPlanApo objective lens, spinning disc Confocal Scanner Unit (CSU10), and
an ICCD camera (XR-Mega10; Stanford Photonics). Images were acquired
using QED software and analyzed by ImageJ (National Institutes of Health).
In ImageJ, images were colored green for presentation.
Protein transformation
Recipient [psi] cells from logarithmically growing cultures were spheroplasted with lyticase. Samples from cell lysis, sedimentation analysis, and
sucrose gradient fractionation were added to the spheroplasts in 1 M sorbitol along with a vector containing the URA3 gene for selection on media
lacking uracil. The cells were incubated at room temperature then recovered at 30°C. Media containing glucose, sorbitol, and agar was added to
the cells before plating on sorbitol plates lacking uracil. Transformants
were replica plated to YPD plates, and individual colonies were picked
from those YPD plates and spotted onto YPD and both media lacking adenine and containing GdHCl for quantification of infectivity.
Purification of Hsp104
Hsp104 was purified as described previously (Lum et al., 2004). Recombinant Hsp104 tagged with a 6x-Histidine tag was expressed in Escherichia
coli cells and affinity purified using a Ni2+-Sepharose column. Next, the 6xHistidine tag was removed by cleavage with the TEV protease and the untagged Hsp104 was separated from the uncleaved, tagged Hsp104 by
affinity purification. The untagged Hsp104 was further purified using anion
exchange via a Q-Sepharose column. The pure Hsp104 collected from the
Q-Sepharose column was then separated on an S-300 gel filtration column
to isolate monomeric Hsp104. Purified, monomeric Hsp104 was pooled,
concentrated, and frozen at 80°C. Multiple purification preparations were
used for all assays in repeat experiments.
ATP hydrolysis assays
ATP hydrolysis was monitored by the Malachite Green assay. 2 µg purified
Hsp104 was equilibrated in buffer (40 mM Tris-HCl, pH 7.5, 175 mM
NaCl, 5 mM MgCl2, and 0.02% Triton X-100) at 37°C before adding
5 mM ATP (Sigma-Aldrich). During incubation of Hsp104 with ATP at
37°C, samples were taken and free phosphate was measured by addition
of Malachite Green dye (Sigma-Aldrich). Color development occurred over
1 min and was terminated by the addition of 34% citric acid (SigmaAldrich). Absorbance was measured at 650 nm.
Glycerol gradients
Purified protein at 75 µg was incubated in buffer (20 mM Tris, pH 8,
100 mM NaCl, 10 mM MgCl2, 2 mM EDTA, and 10% glycerol) ± ATP for

Size-exclusion chromatography
Purified protein at 1 mg/ml was incubated in buffer (50 mM Tris, pH 7.5,
200 mM KCl, 10 mM MgCl2, 2 mM DTT, and 2 mM EDTA) ± ATP for
5 min. The sample was applied to an S-300HR column (GE Healthcare)
and fractions were collected. The concentration of Hsp104 was measured
by Bradford analysis (Bio-Rad Laboratories).
Thermotolerance assays
Cells were grown to mid-log phase at 30°C. An equal number of cells from
each sample were aliquoted and pretreated at 37°C for 30 min. Samples
were heat shocked at 50°C for the indicated amounts of time and then diluted fivefold before plating onto solid rich medium.
In vivo luciferase refolding assay
In vivo luciferase refolding assays were performed as described previously
(Tipton et al., 2008). In brief, cells carrying pRS316GPD-Lux (provided by
B. Bukau, ZMBH, Ruprecht-Karls-Universitat Heidelberg, Germany) were
pretreated at 37°C for 1 h to induce expression of HSP104, then heat
shocked at 44°C for 1 h. After 50 min of heat shock, cycloheximide was
added to prevent new protein synthesis. After heat shock, the cells recovering at 30°C were aliquoted at 15-min intervals and D-luciferin (SigmaAldrich) was added. Luminescence was measured and plotted as a
percentage of total luciferase activity before heat shock.
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SDD-AGE protein analysis
Cells were lysed by bead-beating in buffer A (25 mM Tris-HCl, pH 7.5,
50 mM KCl, 10 mM MgCl2, 1 mM EDTA, 10% glycerol plus mini EDTA-free
protease inhibitors [Roche], Aprotinen [Sigma-Aldrich], and PMSF [SigmaAldrich]). Samples were treated at room temperature for 7 min in sample
buffer containing 2% SDS, then electrophoresed through a 0.1% SDS, 1.5%
agarose gel. The gels were subjected to Western blot with anti-Sup35 antibody. The experiments done with lower SDS concentrations contained 0.01%
SDS in the gel and between 0.05 and 0.1% SDS in the sample buffer, as
indicated. Molecular weight markers were not used because nondenatured
protein aggregates were being analyzed.

5 min on ice before loading onto linear glycerol gradients (15–35%). The
gradients were spun at 34,000 rpm for 18 h in a rotor (SW55; Beckman
Coulter). Gradients were fractionated and the fractions analyzed by SDSPAGE and Western blot with anti-Hsp104 antibody.

Hsp104 shutoff experiments
The diploid strains, HSP104/hsp104::leu2 and HSP104/hsp104-R830S
were transformed with pRS416GAL-HSP104, sporulated, and dissected on
CSM-Ura + 0.25% galactose + 2% raffinose. Low levels of galactose were
used to avoid curing [PSI+] by overexpression of HSP104. Progeny were selected that contained the plasmid and were pink in color as evidence that
[PSI+] was maintained. Cells were grown in CSM-Ura + 0.25% galactose +
2% raffinose for 48 h before switching the cells to glucose media lacking uracil to repress expression of the HSP104 plasmid. At 6-h intervals, aliquots of
the sample were taken and both pelleted for SDD-AGE and plated on CSMUra + 0.25% galactose + 2% raffinose plates. SDD-AGE was performed as
described above. Gels were transferred to PVDF membrane and probed with
anti-Sup35 antibody.
Sup35 solubility assays
Cells were lysed by bead-beating in buffer (10 mM NaPO4, pH 7.5, 250 mM
NaCl, 2% SDS, 1% Triton X-100 plus mini EDTA-free protease inhibitors
[Roche], and PMSF [Sigma-Aldrich]). Lysates were subjected to ultracentrifugation at 100,000 rpm in a rotor (TLA-100; Beckman Coulter) for 1 h. The supernatant was collected and the pellet resuspended in lysis buffer. Total,
supernatant, and pellet fractions were subjected to SDS-PAGE and Western
blot with anti-Sup35 antibody as well as protein transformation.
Sucrose gradients
Cells were lysed by bead-beating in buffer A. Total protein was normalized
to 1 mg/ml and loaded onto a 4-mL linear sucrose gradient (15–60%) and
centrifuged at 32,000 rpm for either 3 or 22 h. To compare infectivity of
soluble and insoluble Sup35 from HSP104 [PSI+] by sucrose gradient, we
increased the time of centrifugation to a time that reproducibly showed a
large fraction of pelletable Sup35. Thus, after a 22-h spin, we are able to
distinguish the soluble Sup35 and the insoluble Sup35 that migrates to the
bottom of the gradient. Gradients were fractionated and the fractions were
analyzed by SDS-PAGE, Western blot, and protein transformation.
Online supplemental material
Fig. S1 shows that the mating of hsp104-R830S cells to HSP104 [psi] cells
results in cells that are phenotypically [PSI+]. Fig. S2 shows that Hsp104R830S forms unstable hexamers by size-exclusion chromatography. Fig. S3 A
shows that growing the cells containing the pRS416-GAL-HSP104 construct
in glucose efficiently represses wild-type HSP104 on the plasmid. Fig. S3 B
shows that hsp104-R830S cells maintain [PSI+] propagons throughout the
shutoff time course as de-repression of wild-type HSP104 results in pink
[PSI+] colonies. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.201307040/DC1.
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